PubMedCrossRef 2. Borrow R, Carlone GM, Rosenstein N, Blake M, Feavers I, Martin D, Zollinger W, Robbins J, Aaberge I, Granoff DM, Miller E, Plikaytis B, van Alphen L, Poolman J, Rappuoli R, Danzig L, Hackell J, Danve B, Caulfield M, Lambert S, Stephens D: EPZ-6438 in vivo Neisseria meningitidis group B correlates of protection and assay standardization. International meeting report
Emory University, Atlanta, Georgia, United States. Vaccine 2006, 24:5093–5107.PubMedCrossRef 3. Finne J, Bitter-Suermann D, Goridis C, Finne U: An IgG monoclonal antibody to group B meningococci cross reacts with developmentally regulated polysialic acid units of glycoproteins in neural and extraneural tissues. J Immunol 1987, 138:4402–4407.PubMed 4. GSK2879552 price Finne J, Leinomen M, Makela PH: Antigenic similarities Salubrinal price between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis. Lancet 1983, 2:355–357.PubMedCrossRef 5. Oster P, Lennon D, O’Hallahan J, Mulholland K, Reid S, Martin D: MeNZB: a safe and highly immunogenic tailor-made vaccine against the New
Zealand Neisseria meningitidis serogroup B disease epidemic strain. Vaccine 2005, 23:2191–2196.PubMedCrossRef 6. Wedege E, Bolstad K, Aase A, Herstad TK, McCallum L, Rosenqvist E, Oster P, Martin D: Functional and specific antibody responces in adult volunteers in New Zealand who were given one of two different meningococcal serogroup B outer membrane vesicle vaccines. Clin Vaccine Immunol 2007, 14:830–838.PubMedCentralPubMedCrossRef 7. Masignani V, Comanducci M, Giuliani MM, Bambini S, Adu-Bobie J, Arico B, Brunelli B, Pieri A, Santini L, Savino S, Serruto D, Litt D, Kroll S, Welsch JA, Granoff DM, Rappuoli R, Pizza M: Vaccination against Neisseria meningitidis Using Three
Variants of the Lipoprotein GNA1870. J Exp Med 2003,197(6):789–799.PubMedCentralPubMedCrossRef GPX6 8. Serruto D, Spadafina T, Ciucchi L, Lewis LA, Ram S, Tontini M, Santini L, Biolchi A, Seib KL, Giuliani MM, Donnelly JJ, Berti F, Savino S, Scarselli M, Costantino P, Kroll JS, O’Dwyer C, Qiu J, Plaut AG, Moxon R, Rappuoli R, Pizza M, Aricò B: Neisseria meningitidis GNA2132, a heparin-binding protein that induces protective immunity in humans. Proc Natl Acad Sci U S A 2010,107(8):3770–3775.PubMedCentralPubMedCrossRef 9. Comanducci M, Bambini S, Brunelli B, Adu-Bobie J, Aricò B, Capecchi B, Giuliani MM, Masignani V, Santini L, Savino S, Granoff DM, Caugant DA, Pizza M, Rappuoli R, Mora M: NadA, a novel vaccine candidate of Neisseria meningitidis . J Exp Med 2002, 195:1445–1454.PubMedCentralPubMedCrossRef 10. Kimura A, Toneatto D, Kleinschmidt A, Wang H, Dull P: Immunogenicity and safety of a multicomponent meningococcal serogroup B vaccine and a quadrivalent meningococcal CRM197 conjugate vaccine against serogroups A, C, W-135, and Y in adults who are at increased risk for occupational exposure to meningococcal isolates. Clin Vaccine Immunol 2011,18(3):483–486.PubMedCentralPubMedCrossRef 11.